Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF -1-
October 17, 2005
- BUSINESS NEWS IN BRIEF -2-
October 17, 2005
- SEMINAR
October 17, 2005
- Betaferon Protects against Progression to Multiple Sclerosis: Schering AG
October 17, 2005
- R&D NEWS IN BRIEF
October 17, 2005
- BUSINESS NEWS IN BRIEF
October 10, 2005
- NEW PRODUCTS
October 10, 2005
- Brand Names of GE Drugs Must Be Based on Their Generic Names: Korosho
October 10, 2005
- Sawai: Survey Indicates Sharp Increase in GE Drug Awareness
October 10, 2005
- Koizumi Expresses Strong Commitment to Social Security Reform
October 10, 2005
- MOF Considering 2nd Medical Fee Cut in FY2006
October 10, 2005
- REGULATORY NEWS IN BRIEF
October 10, 2005
- Interim Report Presented to Improve Environments for IITs
October 10, 2005
- Approval of NPO-operated IRBs Recommended by Expert Group
October 10, 2005
- NHO Introduced 100% Piecework System for Contract Clinical Trial Fees
October 10, 2005
- Japan Should More Actively Participate in Global Clinical Trials: Mr Mori of PMDA
October 10, 2005
- PMDA to Comprehensively Revise Consultation System
October 10, 2005
- R&D NEWS IN BRIEF
October 10, 2005
- JSH Calls for Reduction of Daily Salt Intake to Less Than 6 g
October 10, 2005
- Social Security Benefits Rose 0.8% to \84.3 Trillion in FY2003
October 10, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…